What is LOPJLB’s current signal on VXRT?

LOPJLB’s latest quantitative signal on Vaxart, Inc. (VXRT) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is VXRT in?

Vaxart, Inc. (VXRT) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Vaxart, Inc. (VXRT) do?

Vaxart, Inc. operates as a biotechnology firm currently in the clinical development phase, concentrating its efforts on identifying and advancing novel oral recombinant protein vaccines. The company leverages its unique proprietary platform for delivering these oral vaccine solutions. Its diverse pipeline showcases several promising candidates: An oral tablet vaccine targeting norovirus, which …

Where is Vaxart, Inc. based / listed?

Vaxart, Inc. is based in US, listed on OTC.

Vaxart, Inc. (VXRT)

COMPARE

Healthcare · Biotechnology · OTC · US

$0.43+0.00%Close

SELLCRISIS · day 12

[SCORES & PROFILE]

FUND: 36
VALUE: 40
GROWTH: 75
GARP: 17
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC31.8%

REV YoY-

ROE53.0%

EPS YoY-

ROA23.4%

GROSS

100

NET

[VALUATION]

P/E TTM2.91

P/E FWD-

SECTOR PE20.47

INDUSTRY PE13.95

P/B1.28

P/FCF-

EV/EBITDA1.32

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E9.48

ALTMAN Z-

CURR RATIO1.60

ND/EBITDA-

BETA1.06

Vaxart, Inc. (VXRT)

Key stats

Industry peers

Prediction markets

FUNDAMENTALS

Company news